387
Views
1
CrossRef citations to date
0
Altmetric
Articles/Brief Reports

Re-evaluation of the prognostic significance of oropharyngeal dysphagia in idiopathic inflammatory myopathies

, , , , , & show all
Pages 402-410 | Accepted 07 Jun 2021, Published online: 01 Sep 2021

References

  • Dalakas MC. Sporadic inclusion body myositis--diagnosis, pathogenesis and therapeutic strategies. Nat Clin Pract Neurol 2006;2:437–47.
  • Mulcahy KP, Langdon PC, Mastaglia F. Dysphagia in inflammatory myopathy: self-report, incidence, and prevalence. Dysphagia 2012;27:64–9.
  • Mustafa KN, Dahbour SS. Clinical characteristics and outcomes of patients with idiopathic inflammatory myopathies from Jordan 1996-2009. Clin Rheumatol 2010;29:1381–5.
  • Oldroyd A, Lilleker J, Chinoy H. Idiopathic inflammatory myopathies - a guide to subtypes, diagnostic approach and treatment. Clin Med (Lond) 2017;17:322–8.
  • Lundberg IE, de Visser M, Werth VP. Classification of myositis. Nat Rev Rheumatol 2018;14:269–78.
  • Lundberg IE, Tjärnlund A, Bottai M, Werth VP, Pilkington C, Visser M, et al. 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis 2017;76:1955–64.
  • Selva-O’Callaghan A, Pinal-Fernandez I, Trallero-Araguás E, Milisenda JC, Grau-Junyent JM, Mammen AL. Classification and management of adult inflammatory myopathies. Lancet Neurol 2018;17:816–28.
  • Benbassat J, Gefel D, Larholt K, Sukenik S, Morgenstern V, Zlotnick A. Prognostic factors in polymyositis/dermatomyositis. A computer-assisted analysis of ninety-two cases. Arthritis Rheum 1985;28:249–55.
  • Sugiyama Y, Yoshimi R, Tamura M, Takeno M, Kunishita Y, Kishimoto D, et al. The predictive prognostic factors for polymyositis/dermatomyositis-associated interstitial lung disease. Arthritis Res Ther 2018;20:7.
  • Dankó K, Ponyi A, Constantin T, Borgulya G, Szegedi G. Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases. Medicine (Baltimore) 2004;83:35–42.
  • Azola A, Mulheren R, McKeon G, Lloyd T, Christopher-Stine L, Palmer J, et al. Dysphagia in myositis: a study of the structural and physiologic changes resulting in disordered swallowing. Am J Phys Med Rehabil 2020;99:404–8.
  • Ebert EC. Review article: the gastrointestinal complications of myositis. Aliment Pharmacol Ther 2010;31:359–65.
  • Medsger TA Jr., Robinson H, Masi AT. Factors affecting survivorship in polymyositis. A life-table study of 124 patients. Arthritis Rheum 1971;14:249–58.
  • Carpenter JR, Bunch TW, Engel AG, O’Brien PC. Survival in polymyositis: corticosteroids and risk factors. J Rheumatol 1977;4:207–14.
  • Bochennek K, Luckowitsch M, Lehrnbecher T. Recent advances and future directions in the management of the immunocompromised host. Semin Oncol 2020;47:40–7.
  • Oddis CV, Aggarwal R. Treatment in myositis. Nat Rev Rheumatol 2018;14:279–89.
  • Ortega O, Martín A, Clavé P. Diagnosis and management of oropharyngeal dysphagia among older persons, state of the art. J Am Med Dir Assoc 2017;18:576–82.
  • Ogawa-Momohara M, Muro Y, Kono M, Akiyama M. Prognosis of dysphagia in dermatomyositis. Clin Exp Rheumatol 2019;37:165.
  • Logemann JA, Rademaker AW, Pauloski BR, Ohmae Y, Kahrilas PJ. Normal swallowing physiology as viewed by videofluoroscopy and videoendoscopy. Folia Phoniatr Logop 1998;50:311–9.
  • Bohan A, Peter JB. Polymyositis and dermatomyositis (second of two parts). N Engl J Med 1975;292:403–7.
  • Euwer RL, Sontheimer RD. Amyopathic dermatomyositis (dermatomyositis siné myositis): presentation of six new cases and review of the literature. J Am Acad Dermatol 1991;24:959–66.
  • Griggs RC, Askanas V, DiMauro S, Engel A, Karpati G, Mendell JR, et al. Inclusion body myositis and myopathies. Ann Neurol 1995;38:705–13.
  • András C, Ponyi A, Constantin T, Csiki Z, Szekanecz E, Szodoray P, et al. Dermatomyositis and polymyositis associated with malignancy: a 21-year retrospective study. J Rheumatol 2008;35:438–44.
  • Rommel N, Hamdy S. Oropharyngeal dysphagia: manifestations and diagnosis. Nat Rev Gastroenterol Hepatol 2016;13:49–59.
  • Brodsky MB, Suiter DM, González-Fernández M, Michtalik HJ, Frymark TB, Venediktov R, et al. Screening accuracy for aspiration using bedside water swallow tests: a systematic review and meta-analysis. Chest 2016;150:148–63.
  • Pikus L, Levine MS, Yang Y-X, Rubesin SE, Katzka DA, Laufer I, et al. Videofluoroscopic studies of swallowing dysfunction and the relative risk of pneumonia. AJR Am J Roentgenol 2003;180:1613–16.
  • Kim JS, Kim HJ, Kim JY, Choi HS, Hong J, Kim DY. Characteristics and risk factors of aspiration in lateral medullary infarction. J Korean Dysphagia Soc 2020;10:113–22.
  • Yoon JA, Kim SH, Jang MH, Kim SD, Shin YB. Correlations between aspiration and pharyngeal residue scale scores for fiberoptic endoscopic evaluation and videofluoroscopy. Yonsei Med J 2019;60:1181–6.
  • Rosenbek JC, Robbins JA, Roecker EB, Coyle JL, Wood JL. A penetration-aspiration scale. Dysphagia 1996;11:93–8.
  • Mugii N, Hasegawa M, Matsushita T, Hamaguchi Y, Oohata S, Okita H, et al. Oropharyngeal dysphagia in dermatomyositis: associations with clinical and laboratory features including autoantibodies. PLoS One 2016;11:e0154746.
  • Oh TH, Brumfield KA, Hoskin TL, Stolp KA, Murray JA, Bassford JR. Dysphagia in inflammatory myopathy: clinical characteristics, treatment strategies, and outcome in 62 patients. Mayo Clin Proc 2007;82:441–7.
  • Il OH, Jyne YY, Hyun AS, Koo CS. Inclusion body myositis: a case report. Ann Rehabil Med 2000;24:1229–34.
  • Labeit B, Pawlitzki M, Ruck T, Muhle P, Claus I, Suntrup-Krueger S, et al. The impact of dysphagia in myositis: a systematic review and meta-analysis. J Clin Med 2020;9:2150.
  • Clavé P, Shaker R. Dysphagia: current reality and scope of the problem. Nat Rev Gastroenterol Hepatol 2015;12:259–70.
  • Aggarwal R, Rider LG, Ruperto N, Bayat N, Erman B, Feldman BM, et al. 2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis: an International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Ann Rheum Dis 2017; 76:792–801.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.